What´s New in the Literature on Transradial Intervention

Slides:



Advertisements
Similar presentations
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Advertisements

Can we prevent stent restenosis after coronary stent implantation
The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report.
on behalf of the TOTAL Investigators
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
Asymptomatic Carotid Surgery Trial ACST-2 Collaborators Meeting 2014 Pembroke College, Oxford Is recent coronary stenting a problem (or an opportunity)
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Biondi-Zoccai: Peripheral interventions – metcardio.org Basic principles of peripheral interventions Giuseppe Biondi Zoccai University.
Radial Access Just another artery? Keith G Oldroyd Department of Cardiology Western Infirmary Glasgow.
Radial versus Femoral Approach for Percutaneous Coronary Procedures: A Meta-analysis of Randomized Trials 6th EUROPEAN WORKSHOP ON TRANSRADIAL APPROACH.
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
Revascularizaton of Ischemic DCM Percutaneous Revascularization and Hemodynamic Support Matthew R. Wolff, M.D. University of Wisconsin Disclosures: Cordis.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Growing segment of the population Higher prevalence of CAD
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Ted Feldman MD, FACC, FESC, FSCAI Disclosure Information The following relationships exist: Grant support: Abbott, BSC, Edwards, St Jude, WL Gore Consultant:
Traumatic arterial injuries: endovascular treatment Martha A. Quiodettis May 25, 2010.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Tokuda Hospital Sofia Vascular Surgery and Angiology Department Dr. A. Daskalov, Assoc. Proff. V. Chervenkov.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Outcomes of Older Diabetic Patients After.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA guidelines for percutaneous coronary intervention.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Dr Savvas S Constantinides, MBChB, MD, FRCP Consultant Interventional Cardiologist American Medical Center, Nicosia, Cyprus.
S Ten Tse and Sensibility!
Open cervical approach for carotid artery stenting
Radial Access: Lots of Publicity, But What is the Reality?
Pros and Cons of Radial Access
Impact of Radial Access on Bleeding
Updates From NOTION: The First All-Comer TAVR Trial
Heavily calcified SFA lesions do not avoid the use of 4 F systems
12 Month Outcomes in Patients with Diabetes Mellitus Implanted with a Resolute Zotarolimus-eluting Stent: Initial Results from the RESOLUTE Global Clinical.
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Women, Bleeding, and Coronary Intervention
Why Radial Access Should be the Default for Women undergoing PCI?
Successful CTO PCI Associated with Lower Mortality Risk
Drug Eluting Balloons Bodo Cremers, MD
Transradial Intervention as Access of Choice in STEMI
Radial vs Femoral Access in ACS Patients
Impella 2.5® Device Is Associated with Improved Survival in AMICS
Single Stage CABG and Peripheral Arterial Bypass for Combined Coronary and Peripheral Arterial Disease Divya Arora, Ashok Chahal and Shamsher Singh Lohchab.
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Effect of Obesity on In-Hospital Mortality in Patients with Cardiogenic Shock Complicating AMI Obesity is paradoxically associated with favorable mortality.
Catheter-Based Treatment of Coronary Artery Disease
Death, target vessel revascularisation (TVR) and myocardial infarction (MI) with bioresorbable vascular scaffold (BVS) versus drug-eluting stent (DES)
Compare-Acute Trial design: STEMI patients undergoing primary PCI were randomized to fractional flow reserve (FFR)-guided complete revascularization (n.
Fewer PCIs After Public Reporting Changes in NY
Figure 2 Ischaemic and bleeding outcomes in the major clinical trials
Giuseppe Biondi Zoccai, MD
AN INTERNATIONAL COLLABORATIVE META-ANALYSIS ON 1,274 PATIENTS UNDERGOING PERCUTANEOUS DRUG-ELUTING STENTING FOR UNPROTECTED LEFT MAIN CORONARY ARTERY.
NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.
Randomized Comparison in the Setting of Acute MI
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Large-Scale Registry Examining Safety and Effectiveness of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Western.
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
Comparison of radial versus femoral access in patients undergoing invasive management for acute coronary syndromes: evidence from a systematic review and.
Maintenance of Long-Term Clinical Benefit with
ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions J. Mehilli, MD Deutsches Herzzentrum Technische.
Atlantic Cardiovascular Patient Outcomes Research Team
IVUS-XPL Trial design: Patients undergoing drug-eluting stent implantation for long coronary lesions were randomized to IVUS-guided PCI (n = 700) vs. angiography-guided.
The American College of Cardiology Presented by Dr. A. Abazid
NOBLE Trial design: Patients with unprotected left main disease were randomized to either PCI with a drug-eluting stent (DES) (88% biolimus) or CABG. They.
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

What´s New in the Literature on Transradial Intervention Wolfgang Schöls Duisburg Heart Center Department of Cardiology, Angiology and Electrophysiology Department of Pediatric Cardiology and Congenital Heart Disease Department of Cardiac Surgery

What´s not quite new.... ....but quite nice anyway

Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials Jolly SS et al., Am Heart J 2009 less major bleedings trend towards reduced incidence of death, MI or stroke

What´s new in the literature.... ....regarding indications for transradial interventions

Transradial vs Transfemoral Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis Singh S et al., Can J Cardiol 2016 Meta-analysis of 16 randomized controlled trials comprising data from 9726 patients all-cause mortality major bleeding access site bleeding major adverse cardiovascular events stroke * * * * n. s. -90% -80% - 70% -60% -50% -40% -30% -20% -10% 0 +10% +20% +30% relative risk transradial vs. transfemoral

Transradial vs transfemoral approach for percutaneous coronary intervention in cardiogenic shock: A radial-first centre experience and meta-analysis of published studies Roule V et al., Arch Cardiovasc Dis 2015

death RR 63% major bleeding RR 44% transfusions RR 57%

Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations from a National Percutaneous Coronary Intervention Database Mamas MA et al., Circulation 2016 2005 – 2012: Increase in TRA use from 14% to 58.6% in 417 038 PCI patients logistic regression analysis: Increase in TRA use independently associated with a decrese in 30-day mortaliy odds ratio 0.70 (95% confidence interval 0.66 – 0.77)

Transradial versus transfemoral rotablation for heavily calcified coronary lesions in contemporary drug-eluting stent Era Yin WH et al., J Geriatr Cardiol 2015 6 F 59%; 7 F 31%,; 8 F 10% 126 consecutive patients with heavily calcified coronary lesions 59 transradial Rotablation PTCA DES-Implantation in 90% 67 transfemoral 6 F 10%; 7 F 78%, 8 F 12% transradial transfemoral procedural success rate 97% 99% death, myocardial infarction 4% 7% major access site bleeding 2% 16% * length of hospital stay 5.1±16,5 days 9.2±20.6 days

What´s new in the literature.... ....regarding technical developments

Size of the radial artery 2.6 ± 0.4 (1.2 – 4.0) mm (Yoo et al. 2005)

First prospective multicenter experience with the 7 French Glidesheath Slender for complex transradial coronary interventions Aminian A et al., Catheter Cardiovasc Interv 2016 Prospective multicenter registry of complex TR PCI cases in 60 patients distal left main stenosis (n = 20) complex bifurcation lesions (n = 16) chronic total occlusions (n = 15) lesions requiring rotablation (n = 10) procedural success 97% access site crossover 1 (1.6%) vascular access site complications 3 (4.7%) major bleeding 0 radial spasm 7 (11%) radial artery occlusion at 1 month 3 (4.7%)

outer diameter < 6 F guide inner diameter like 7 F guide Harding, Heart, Lung and Circulation 2013; 22: 188-192

Effectiveness and Safety of the Transradial 8 Fr Sheathless Approach for Revascularization of Chronic Total Occlusions Dautov R et al., Am J Cardiol 2016 sheathless transradial technique with regular 8 Fr catheters applied in 119 patients biradial approach (8 F side and 6 F side) used in 28 patients (24%) 119 Technical success rate 93% No major vascular or bleeding complications Grade III radial hematomas 4 (3%) No increase in procedure time, contrast use, radiation dose Doppler follow-up 3 – 6 months post procedure in biradial patients, Radial artery occlusions: 8 Fr side 2, 6 Fr side 1

George S, Mamas MA, Nolan J, Ratib K Radial artery perforation treated with balloon tracking and guide catheter tamponade - A case series George S, Mamas MA, Nolan J, Ratib K Cardiovasc Revasc Med 2016

What´s new in the literature.... ....regarding non-coronary interventions

Comparison of Transradial vs Transfemoral Access for Aortoiliac and Femoropopliteal Interventions: A Single-Center Experience Roy AK et al., J Endovasc Ther 2016 188 patients with lower limb claudication or critical limb ischema aortoiliac (62%) or femoropopliteal (38%) interventions on 210 lesions transfemoral access 65% transradial access 35% transfemoral transradial crossover rate 7.3 % 16.9 % access site complications 6.0 % 3.7 % procedure time 50 ± 29 min 47 ± 25 min length of stay 2.2 ± 0.6 days 2.1 ± 0.3 days

Transradial Approach for Noncoronary Interventions: A Single-Center Review of Safety and Feasibility in the First 1,500 Cases Posham R et al., J Vasc Interv Radiol 2016 Transradial Access for Visceral Endovascular Interventions in Morbidly Obese Patients: Safety and feasibility Biederman DM et al., J Vasc Access 2016 Transradial and Transfemoral Percutaneous Closure of Iatrogenic Perimembraneous Ventricular Septal Defects Using the Amplatzer AVP IV Device Weeraman D et al., International J Cardiol 2016

Transradial approach for ... ... renal artery stenting

Transradial approach for ... ... subclavian artery stenting

Transradial approach for ... ... carotid artery stenting

Transradial approach for ... ... vertebrobasilar stenting

Transradial approach for ... ... urbi et orbi